Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations
Top Cited Papers
Open Access
- 3 November 2020
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 40 (2) , 355-368
Abstract
Lung adenocarcinoma (LUAD) harboring EGFR mutations prevails in Asian population. However, the inter-patient and intra-tumor heterogeneity has not been addressed at single-cell resolution. Here we performed single-cell RNA sequencing (scRNA-seq) of total 125,674 cells from seven stage-I/II LUAD samples harboring EGFR mutations and five tumor-adjacent lung tissues. We identified diverse cell types within the tumor microenvironment (TME) in which myeloid cells and T cells were the most abundant stromal cell types in tumors and adjacent lung tissues. Within tumors, accompanied by an increase in CD1C+ dendritic cells, the tumor-associated macrophages (TAMs) showed pro-tumoral functions without signature gene expression of defined M1 or M2 polarization. Tumor-infiltrating T cells mainly displayed exhausted and regulatory T-cell features. The adenocarcinoma cells can be categorized into different subtypes based on their gene expression signatures in distinct pathways such as hypoxia, glycolysis, cell metabolism, translation initiation, cell cycle, and antigen presentation. By performing pseudotime trajectory, we found that ELF3 was among the most upregulated genes in more advanced tumor cells. In response to secretion of inflammatory cytokines (e.g., IL1B) from immune infiltrates, ELF3 in tumor cells was upregulated to trigger the activation of PI3K/Akt/NF-κB pathway and elevated expression of proliferation and anti-apoptosis genes such as BCL2L1 and CCND1. Taken together, our study revealed substantial heterogeneity within early-stage LUAD harboring EGFR mutations, implicating complex interactions among tumor cells, stromal cells and immune infiltrates in the TME.Keywords
This publication has 79 references indexed in Scilit:
- The Prognostic Implications of Macrophages Expressing Proliferating Cell Nuclear Antigen in Breast Cancer Depend on Immune ContextPLOS ONE, 2013
- Activator protein 1 suppresses antitumor T-cell function via the induction of programmed death 1Proceedings of the National Academy of Sciences, 2012
- Neuroepithelial body microenvironment is a niche for a distinct subset of Clara-like precursors in the developing airwaysProceedings of the National Academy of Sciences, 2012
- Evidence for type II cells as cells of origin of K-Ras–induced distal lung adenocarcinomaProceedings of the National Academy of Sciences, 2012
- Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusionOncogene, 2012
- MUC1-C Oncoprotein Functions as a Direct Activator of the Nuclear Factor-κB p65 Transcription FactorCancer Research, 2009
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Nuclear factor-κB in cancer development and progressionNature, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002